Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Atherosclerosis IV: Nursing Management

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Pharmacogenomics and Placebo Response in a Randomized Clinical Trial in Asthma.

Clinical pharmacology and therapeutics·2019

Same author

Developing new drug treatments in the era of network medicine.

Clinical pharmacology and therapeutics·2012

Same author

Detection of nitrosated proteins.

Current protocols in toxicology·2012

Same author

Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells.

Amino acids·2011

Same author

The antithrombotic effects of organic nitrates.

Trends in cardiovascular medicine·2011

Same author

New directions in thrombolytic therapy Molecular mutants and biochemical conjugates.

Trends in cardiovascular medicine·2011

Search research articles

Video Experimental Relacionado

Updated: Jul 7, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 8, 2013

La relación entre la aterosclerosis y la trombosis.

¹Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.

|December 1, 1992

Resumen

La aterosclerosis y la trombosis comparten mecanismos moleculares. Comprender estos determinantes trombóticos en la aterogénesis ofrece una visión más clara del desarrollo de la enfermedad.

Área de la Ciencia:

Biología Cardiovascular Biología Cardiovascular
Investigación de la trombosis.
La patogénesis y la patogénesis de la aterosclerosis.

Sus antecedentes:

El vínculo entre la aterosclerosis y la trombosis está establecido desde hace mucho tiempo, pero se entiende mal a nivel molecular.
Históricamente, esta asociación se basó en datos de observación, sin conocimientos mecanicistas.

Objetivo del estudio:

Para dilucidar los mecanismos moleculares y celulares que vinculan la aterosclerosis y la trombosis.
Explorar la regulación y modulación de los factores trombóticos en la aterogénesis.

Principales métodos:

Revisión de las asociaciones conocidas entre los determinantes de la trombosis (plaquetas, fibrina, enzimas fibrinolíticas) y la aterosclerosis.
Análisis de la citoquina, el factor de crecimiento y la lipoproteína (especialmente la lipoproteína) regulación de los factores trombóticos.

Más Videos Relacionados

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

Videos de Experimentos Relacionados

Last Updated: Jul 7, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 8, 2013

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

Principales resultados:

Discute las asociaciones entre los principales determinantes de la trombosis y la aterosclerosis.
Destaca el papel de las citoquinas, los factores de crecimiento y las lipoproteínas aterogénicas en la regulación de los factores trombóticos.
Explica la modulación de los determinantes trombóticos por las lipoproteínas.

Conclusiones:

Mecanismos moleculares y celulares emergentes aclaran los fundamentos trombóticos de la aterogénesis.
Proporciona una comprensión fundamental de cómo la trombosis contribuye al desarrollo de la aterosclerosis.